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Background: Transcatheter aortic valve replacement (TAVR) is a viable option for patients with symptomatic severe aortic stenosis who 
are considered high risk for surgical valve replacement. After TAVR, conduction abnormalities requiring permanent pacemaker (PPM) 
implantation, as well as paravalvular aortic insufficiency (AI), have been reported. Three generations of balloon-expandable Edwards 
SAPIEN valves are in use, but relative rates of post-TAVR PPM implantation and paravalvular AI are unknown. We evaluated PPM 
implantation and paravalvular AI after TAVR for the 1st generation commercial (C) SAPIEN, SAPIEN XT (XT), and SAPIEN 3 (S3) valves.
methods: We followed 160 patients (75 C, 50 XT, and 35 S3) without a prior PPM or implantable cardiac defibrillator who underwent TAVR 
for symptomatic severe AS. One patient died during TAVR, and was excluded. We evaluated the incidence of PPM implantation during 
the index hospitalization and the degree of paravalvular AI post-TAVR. Univariable and multivariable predictors of PPM implantation were 
evaluated.
results: The population (80±9 years old, 53% male) had a mean STS score of 8.4±4.8, AV area 0.7±0.2 cm2, AV gradient 51±13 mmHg, 
and LVEF 55±12%. There were no differences in baseline patient clinical characteristics between the 3 groups of valve models. PPM was 
implanted in 6 (8%) C, 7 (14%) XT, and 9 (26%) S3 patients (p=0.04). On multivariable analysis, valve model and complete heart block 
during TAVR placement were the only independent predictors of post-TAVR PPM placement. S3 valve implantation resulted in significantly 
less echocardiographic moderate/severe paravalvular AI (11% C, 14% XT, 0% S3; p=0.026).
conclusion:  TAVR using the S3 model valve prosthesis is associated with a higher rate of PPM implantation and less moderate/severe 
paravalvular aortic insufficiency compared with the earlier generation Edwards SAPIEN valves.
